Although a series of clinical guidelines on rational insulin use for patients with T2D have been proposed by experts4, insulin dosage titration is typically based on the clinical guidance combined with physicians’ experience to achieve targeted glycemic goals5 and cannot fully take into consideration the variability for each patient in the real world6,7. This evidence concerns the gene INS and type 2 diabetes mellitus.